SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2025)

SOPHiA GENETICS has disclosed Net Cash Flow across 6 years of filings, most recently posting -$12.0 million for Q4 2025.

• Net Cash Flow for Q4 2025 came in at -$12.0 million, up 7.13% year-over-year; the trailing twelve-month figure through Dec 2025 was -$14.2 million (up 63.51% YoY), and the FY2025 annual result was -$14.2 million, up 63.51% from the prior year.
• Net Cash Flow came in at -$12.0 million for Q4 2025 at SOPHiA GENETICS, up from -$13.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $168.8 million in Q3 2021 to a low of -$20.8 million in Q3 2022.
• The 5-year median for Net Cash Flow is -$12.2 million (2021), against an average of -$156050.0.
• Across the five-year window, Net Cash Flow slumped 1915.5% in 2023 and soared 1596.8% in 2025, its largest moves.
• SOPHiA GENETICS's Net Cash Flow stood at -$17.2 million in 2021, then surged by 103.42% to $587000.0 in 2022, then plunged by 1915.5% to -$10.7 million in 2023, then fell by 21.54% to -$13.0 million in 2024, then climbed by 7.13% to -$12.0 million in 2025.
• The last three Net Cash Flow figures came in at -$12.0 million (Q4 2025), -$13.3 million (Q3 2025), and $23.9 million (Q2 2025), per Business Quant data.